Galixir
Galixir uses AI to speed drug discovery by generating high-quality preclinical candidates and reducing time and cost for R&D teams. It combines machine learning and proprietary algorithms with computational chemistry, medicinal chemistry, computational biology and cloud computing through its Pyxir™ AI-driven drug discovery platform to design and screen novel molecules. The platform supports candidate optimization, patentability assessment, and collaborative projects with pharmaceutical companies and research institutions. Galixir operates as a B2B AI drug discovery platform serving pharma and biotech partners across multiple indications.
Galixir
Galixir uses AI to speed drug discovery by generating high-quality preclinical candidates and reducing time and cost for R&D teams. It combines machine learning and proprietary algorithms with computational chemistry, medicinal chemistry, computational biology and cloud computing through its Pyxir™ AI-driven drug discovery platform to design and screen novel molecules. The platform supports candidate optimization, patentability assessment, and collaborative projects with pharmaceutical companies and research institutions. Galixir operates as a B2B AI drug discovery platform serving pharma and biotech partners across multiple indications.